FDA Launches the Digital Health Center of Excellence
The FDA’s DHCoE aims to advance healthcare through encouraging responsible and high-quality digital health innovation. The scope of the center will include mobile health devices, wearables, SaMD (Software as a Medical Device), and more.
In this infographic, CBPartners outlines the DHCoE’s objectives and offers insightful key takeaways about the challenges and opportunities that the launch of this CoE presents.
Read the infographic here.
If you are interested in reading more about the digital therapeutics landscape, read related posts in the expertise team’s thought leadership channel.